WCK-5222 | Zidebactam/Cefepime | Gram-Negative Pathogens

Zaynich® (Zidebactam/Cefepime, WCK 5222) achieves over 97% efficacy in clinical study for serious infections caused by Meropenem-Resistant gram-negative pathogens

Ref: Wockhardt Jan 2025